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Dosage form “spray” is one of the most advanced and modern methods of 
injection of drugs in the human body. The advantage of air- drip method of drug 
delivery (inhalation) compared to injectable and enteral methods are the possibility of 
direct and rapid impact on the area inflammation of mucous membranes or when fine 
evaporation – the bronchi and lungs [1]. 
Wound healing - a complex process characterized by different levels of 
structural organization. An important problem of modern medicine is the growth rate 
continued unhealed wounds. Therefore, the goal and purpose of this research is the 
choice of adequate treatment of wound healing, including not only physical 
techniques, but in most cases involves the recruitment, development and research of 
effective drugs [2]. 
At JSC “Pharmac” has developed a wound healing drug EfialTM in a dosage 
form of spray. As reference drug of the drug at pharmacological action was elected 
Solcoseril, in jelly form (Legacy Pharmaceuticals International – Switzerland). A lot 
of different researches were conducted on the base of this drug. Two of them were 
provided in this article [3]. 
In the beginning was investigated wound healing effect of the drug EfialTM, 
in dosage form of spray which consists of a concentrate deproteinised layer of the pig 
skin, based on peptides of 0,12 mg/ml and phosphatidyicholine of 100 mg/ml 
produced by JSC “Pharmac” was studied. On flat wounds model of 1 cm2 in the 
experiments using white rats was proved that the investigational drug Efial in spray 
form and the reference drug “Solcoseril” in jelly form when applied topically can 
show a similar regenerative healing effect. That is shown by an effective reduction of 
the area of the wound in all periods of observation as well as the drugs provided a 
similar reduction of toxemia, as it evidenced by the decrease in the permeability of 
the erythrocyte membrane and reduction of average - molecular peptides in blood 
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serum [4]. 
The second investigation is about the effectiveness of antimicrobial 
preservatives of spray “Efial”. Testing the effectiveness of antimicrobial 
preservatives (sodium salt propylparahydroxybenzoate – 0.18 mg / ml sodium 
meathylparahydroxybenzoate – 1.62 mg / ml) in sprays “Efial.” It is proved that the 
chosen preservatives ensure microbiological purity of the drug during storage at 2 to 
8 ° C. To ensure proper microbiological purity of the drug during its use after 
opening the primary packaging, the following measures: 
• introduced filtration through a filter with a pore size of 0.22 microns, which 
provides a necessary degree of microbiological purity of the drug; 
• set the storage mode at 2 to 8 ° C – which is not the reproduction of 
microorganisms in the sample; 
• limited term use of the drug after opening – up to 7 days [5]. 
Thus, the development of the drug helped solve the problem of wound 
healing. It was decided due to the development of innovative drug Efial JSC 
"Pharmac". The company is implementing an increasing number of highly efficient 
drugs and pharmaceutical industry raises Ukraine at the international level. 
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